{"id":"ic","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":{"setId":"37dc44aa-17b2-8721-e063-6294a90a34f6","title":"MENTHOLATUM NATURAL ICE - ORIGINAL, SPF 15 ORIGINAL (DIMETHICONE, OCTINOXATE, OCTISALATE) STICK [THE MENTHOLATUM COMPANY]"},"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Interferon-alpha (IC) is a type of cytokine that plays a crucial role in the body's natural defense against viral infections and cancer. It works by binding to specific receptors on the surface of cells, triggering a cascade of signaling events that ultimately lead to the activation of immune cells and the production of other cytokines that help to eliminate infected cells and tumor cells.","oneSentence":"Interferon-alpha (IC) works by stimulating the body's immune system to fight viral infections and cancer.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:15:22.347Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05646316","phase":"PHASE3","title":"Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer","status":"RECRUITING","sponsor":"NRG Oncology","startDate":"2022-12-07","conditions":"Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8","enrollment":428},{"nctId":"NCT04432207","phase":"PHASE1","title":"A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer","status":"TERMINATED","sponsor":"Imugene Limited","startDate":"2020-11-30","conditions":"Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV","enrollment":24},{"nctId":"NCT02870738","phase":"PHASE2","title":"Bladder Directed vs. Pelvic Floor Therapy in IC/BPS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Corewell Health East","startDate":"2017-04-21","conditions":"Cystitis, Interstitial, Painful Bladder Syndrome","enrollment":128},{"nctId":"NCT06693908","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis","status":"RECRUITING","sponsor":"Genentech, Inc.","startDate":"2025-03-31","conditions":"Moderate to Severe Ulcerative Colitis","enrollment":24},{"nctId":"NCT06744036","phase":"NA","title":"Effects of Including Interferential Current in a Therapeutic Exercise Program in Individuals With Knee Osteoarthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Nove de Julho","startDate":"2025-01-20","conditions":"Osteoarthritis, Knee","enrollment":138},{"nctId":"NCT06865053","phase":"","title":"Screening for Heart Failure in General Medicine Consultations","status":"COMPLETED","sponsor":"Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer","startDate":"2025-03-14","conditions":"Heart Failure","enrollment":216},{"nctId":"NCT07467720","phase":"NA","title":"Study to Evaluate the Clinical Utility of Radiation Exposure Reduction: Multi-site Rampart Guardian Peripheral Trial","status":"NOT_YET_RECRUITING","sponsor":"Baylor Research Institute","startDate":"2026-05-15","conditions":"Radiation Protection","enrollment":75},{"nctId":"NCT05941741","phase":"PHASE3","title":"IC Plus Low-dose Radiation Plus Cadonilimab in LANPC","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2024-01-10","conditions":"Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy","enrollment":380},{"nctId":"NCT07477561","phase":"NA","title":"Optimizing INtrinsic Capacity for Functional INdependence and to Impede FrailTY in Older Adults: Adaptation of the WHO-ICOPE for Healthy Ageing in Singapore","status":"RECRUITING","sponsor":"Sengkang General Hospital","startDate":"2023-07-17","conditions":"Frailty in Older Adults, Intrinsic Capacity, Age-related Functional Decline","enrollment":600},{"nctId":"NCT04878263","phase":"NA","title":"Evaluation and Support Care Process Within the Care Pathway of Heart Failure Patients","status":"COMPLETED","sponsor":"Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer","startDate":"2021-06-28","conditions":"Heart Failure Acute","enrollment":361},{"nctId":"NCT07475468","phase":"","title":"CP382 - Intermittent Catheter (IC) PRO Panel Plan","status":"NOT_YET_RECRUITING","sponsor":"Coloplast A/S","startDate":"2026-03-12","conditions":"Intermittent Catheterization","enrollment":1000},{"nctId":"NCT06603246","phase":"PHASE1, PHASE2","title":"A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease","status":"RECRUITING","sponsor":"Genentech, Inc.","startDate":"2024-11-18","conditions":"Non-cystic Fibrosis Bronchiectasis, Chronic Obstructive Pulmonary Disease","enrollment":128},{"nctId":"NCT05735184","phase":"PHASE1","title":"A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML","status":"RECRUITING","sponsor":"Kura Oncology, Inc.","startDate":"2023-07-18","conditions":"Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation, Refractory AML","enrollment":420},{"nctId":"NCT06504381","phase":"PHASE1, PHASE2","title":"DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-01-08","conditions":"High Grade Glioma, MGMT-Unmethylated Glioblastoma, MGMT-Methylated Glioblastoma","enrollment":70},{"nctId":"NCT07459790","phase":"PHASE2, PHASE3","title":"The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis With Hunner's Lesions","status":"RECRUITING","sponsor":"JSC NextGen","startDate":"2023-12-29","conditions":"IC, Hunner Type Interstitial Cystitis, Bladder Pain Syndrome","enrollment":180},{"nctId":"NCT00833599","phase":"","title":"Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders","status":"ENROLLING_BY_INVITATION","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2009-01","conditions":"Lymphedema, Lymphatic Disorders, Lipedema","enrollment":283},{"nctId":"NCT04420975","phase":"PHASE1","title":"Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2020-10-14","conditions":"Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Myxofibrosarcoma","enrollment":14},{"nctId":"NCT06246799","phase":"PHASE3","title":"Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2024-11-07","conditions":"Type 2 Diabetes (Adult Onset)","enrollment":256},{"nctId":"NCT07092865","phase":"PHASE2","title":"A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant","status":"RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2025-08-06","conditions":"Respiratory Syncytial Virus Infections","enrollment":184},{"nctId":"NCT06239727","phase":"PHASE3","title":"Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2024-03-01","conditions":"Nasopharyngeal Carcinoma","enrollment":593},{"nctId":"NCT05755386","phase":"PHASE3","title":"Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2023-10-02","conditions":"IC-MPGN","enrollment":106},{"nctId":"NCT07166094","phase":"PHASE3","title":"Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer","status":"RECRUITING","sponsor":"Genmab","startDate":"2025-11-28","conditions":"Endometrial Cancer, Recurrent or Progressive Endometrial Cancer","enrollment":544},{"nctId":"NCT07444606","phase":"PHASE1","title":"Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases","status":"NOT_YET_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2026-08-31","conditions":"Melanoma","enrollment":50},{"nctId":"NCT07442721","phase":"NA","title":"Sacral ESPB vs. PENG Block for Hip Hemiarthroplasty Analgesia","status":"RECRUITING","sponsor":"Fayoum University Hospital","startDate":"2026-02-01","conditions":"Hip Arthroplasty, Hip Fracture Surgeries, Femoral Neck Fractures","enrollment":80},{"nctId":"NCT06619236","phase":"PHASE3","title":"Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Genmab","startDate":"2025-02-07","conditions":"Platinum-resistant Ovarian Cancer","enrollment":530},{"nctId":"NCT06989359","phase":"PHASE2","title":"Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease","status":"RECRUITING","sponsor":"ADARx Pharmaceuticals, Inc.","startDate":"2025-08-28","conditions":"IgAN, C3G, Complement-mediated Kidney Disease","enrollment":45},{"nctId":"NCT07381920","phase":"NA","title":"Effects of Muscle Cooling on Motor Unit Firing of the Quadriceps","status":"RECRUITING","sponsor":"Wake Forest University","startDate":"2026-01-20","conditions":"Healthy","enrollment":24},{"nctId":"NCT05645523","phase":"EARLY_PHASE1","title":"Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2023-10-24","conditions":"Solid Tumor","enrollment":25},{"nctId":"NCT03955445","phase":"PHASE3","title":"Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2019-10-03","conditions":"C3 Glomerulopathy, Immune-complex-membranoproliferative Glomerulonephritis","enrollment":225},{"nctId":"NCT07421167","phase":"PHASE2","title":"A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)","status":"NOT_YET_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2026-06-29","conditions":"Primary Immune Thrombocytopenia (ITP), Primary Evans Syndrome (ES)","enrollment":164},{"nctId":"NCT05991622","phase":"PHASE2","title":"Combined Injectable Treatment for HIV and OUD","status":"WITHDRAWN","sponsor":"Rhode Island Hospital","startDate":"2022-04-01","conditions":"Human Immunodeficiency Virus, Opioid Use Disorder","enrollment":""},{"nctId":"NCT07405671","phase":"PHASE4","title":"Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2026-09","conditions":"Atrial Fibrillation (AF), Coronary Artery Disease","enrollment":988},{"nctId":"NCT05682118","phase":"NA","title":"Impact of Dynamic CoROnary RoADmap System for Guidance of Instantaneous Wave-Free Ratio or Fractional Flow Reserve","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2023-07-31","conditions":"Ischemic Heart Disease","enrollment":226},{"nctId":"NCT07392580","phase":"PHASE2","title":"Intralesional Chemotherapy (IC): Cisplatin + Epinephrine","status":"NOT_YET_RECRUITING","sponsor":"University of Miami","startDate":"2026-04-01","conditions":"Laryngeal Squamous Cell Carcinoma","enrollment":20},{"nctId":"NCT07391306","phase":"PHASE2, PHASE3","title":"The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis Without Hunner's Lesions.","status":"RECRUITING","sponsor":"JSC NextGen","startDate":"2024-02-16","conditions":"IC, Interstitial Cystitis and Bladder Pain Syndrome, Interstitial Cystitis, Chronic","enrollment":180},{"nctId":"NCT06521086","phase":"NA","title":"Optimizing Recovery in Trauma Patients by Integrating Enhanced Nutrition Delivery","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-04-01","conditions":"Trauma, Critical Illness","enrollment":60},{"nctId":"NCT03953144","phase":"PHASE1, PHASE2","title":"Synapse 3D With Intravascular Indocyanine Green","status":"RECRUITING","sponsor":"St. Joseph's Healthcare Hamilton","startDate":"2022-12-01","conditions":"Non-small Cell Lung Cancer, Primary Neoplasm","enrollment":32},{"nctId":"NCT02570815","phase":"PHASE1","title":"Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer","status":"RECRUITING","sponsor":"St. Joseph's Healthcare Hamilton","startDate":"2016-10","conditions":"Non-small Cell Lung Cancer","enrollment":250},{"nctId":"NCT03856632","phase":"PHASE4","title":"Liraglutide Effect in Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2019-03-18","conditions":"Atrial Fibrillation","enrollment":60},{"nctId":"NCT06394830","phase":"PHASE2","title":"Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)","status":"RECRUITING","sponsor":"Vaneltix Pharma, Inc.","startDate":"2024-12-13","conditions":"Interstitial Cystitis, Bladder Pain Syndrome","enrollment":50},{"nctId":"NCT03020030","phase":"PHASE3","title":"Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2017-03-03","conditions":"Acute Lymphoblastic Leukemia, Pediatric","enrollment":560},{"nctId":"NCT05737121","phase":"PHASE2","title":"Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS","status":"RECRUITING","sponsor":"Vaneltix Pharma, Inc.","startDate":"2023-05-22","conditions":"Interstitial Cystitis, Bladder Pain Syndrome","enrollment":120},{"nctId":"NCT07355803","phase":"NA","title":"Define Final Selection Choice Criteria for a Coloplast Catheter Ensuring Highest Patient Satisfaction Via Surveys (EVA).","status":"RECRUITING","sponsor":"Coloplast NV/SA","startDate":"2025-10-21","conditions":"Neurogenic Bladder Disorder, Non-Neurogenic Bladder, Bladder Dysfunction","enrollment":107},{"nctId":"NCT06299683","phase":"NA","title":"Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2024-05-01","conditions":"Chronic Interstitial Cystitis, Bladder Pain Syndrome, Painful Bladder Syndrome","enrollment":220},{"nctId":"NCT07350941","phase":"NA","title":"Impact of Cardiac Rehabilitation Adapted for Patients With Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Puerta de Hierro University Hospital","startDate":"2026-01-30","conditions":"Heart Failure","enrollment":114},{"nctId":"NCT01169194","phase":"","title":"Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2003-06","conditions":"Inflammatory Bowel Disease","enrollment":2400},{"nctId":"NCT01169207","phase":"","title":"Johns Hopkins Crohn's Disease and Ulcerative Colitis Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"1996-07","conditions":"Inflammatory Bowel Disease","enrollment":2500},{"nctId":"NCT01171872","phase":"","title":"Gene Expression in Inflammatory Bowel Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Johns Hopkins University","startDate":"1999-11","conditions":"Inflammatory Bowel Disease","enrollment":1100},{"nctId":"NCT06371326","phase":"PHASE1","title":"A Study of ZT002 Injection in Participants With Overweight or Obesity","status":"COMPLETED","sponsor":"Beijing QL Biopharmaceutical Co.,Ltd","startDate":"2023-11-21","conditions":"Overweight or Obesity","enrollment":28},{"nctId":"NCT05720910","phase":"NA","title":"Streamlined Geriatric and Oncological Evaluation Based On IC Technology","status":"RECRUITING","sponsor":"Institut Bergonié","startDate":"2024-10-15","conditions":"Breast Cancer, Comorbidities and Coexisting Conditions, Lung Cancer","enrollment":720},{"nctId":"NCT07343440","phase":"NA","title":"Trial on the Impact of Indirect Calorimetry-Guided Nutritional Support on Patient-Centered Outcomes in Critically Ill Patients - The OPTICal Study","status":"NOT_YET_RECRUITING","sponsor":"HEIDEGGER CP","startDate":"2026-01-01","conditions":"Critical Illness, ICU","enrollment":356},{"nctId":"NCT06039371","phase":"PHASE2","title":"Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study","status":"RECRUITING","sponsor":"University of Washington","startDate":"2024-05-21","conditions":"Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8","enrollment":69},{"nctId":"NCT07340112","phase":"","title":"Expression of GLP1 Receptor on Peripheral Blood Mononuclear Cells in Advanced Peripheral Artery Disease: Paving the Way for GLP1R Agonists Treatment in Chronic Limb Threatening Ischemia","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Strasbourg, France","startDate":"2026-06","conditions":"Peripheral Arterial Disease (PAD), Claudication, Intermittent, Chronic Limb-Threatening Ischemia","enrollment":50},{"nctId":"NCT07336433","phase":"NA","title":"SMART-IC-Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"SyMap Medical (Suzhou), Ltd.","startDate":"2026-01-01","conditions":"Hypertensive Disease","enrollment":15},{"nctId":"NCT05544695","phase":"","title":"Real-world Evidence Study on Cystistat","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2022-10-21","conditions":"Interstitial Cystitis and Bladder Pain Syndrome","enrollment":74},{"nctId":"NCT06366269","phase":"NA","title":"Acupuncture First for IC/BPS","status":"RECRUITING","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2025-01-21","conditions":"Bladder Pain Syndrome, Interstitial Cystitis","enrollment":34},{"nctId":"NCT06332079","phase":"PHASE2","title":"Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer Patients","status":"TERMINATED","sponsor":"Gruppo Oncologico del Nord-Ovest","startDate":"2024-03-13","conditions":"Colorectal Cancer Metastatic","enrollment":4},{"nctId":"NCT07305363","phase":"","title":"A Prospective, Open-label, Single-arm, Investigator-initiated Study (SELIC) to Evaluate the Efficacy and Safety of Seladelpar in Adult Liver Transplant Recipients With Ischemic Cholangiopathy (IC).","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Diego","startDate":"2026-02","conditions":"Liver Transplant; Complications, Ischemic Cholangiopathy","enrollment":10},{"nctId":"NCT06282328","phase":"","title":"HIV HOspital TEsting: Bringing the Hidden to Light in the Hospital Setting","status":"COMPLETED","sponsor":"Castagna Antonella","startDate":"2024-02-14","conditions":"Hiv, HIV Infections, AIDS","enrollment":300},{"nctId":"NCT07270848","phase":"PHASE4","title":"Dronedarone Rhythm Intervention for Early Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Inha University Hospital","startDate":"2026-01-01","conditions":"Atrial Fibrillation (AF)","enrollment":1898},{"nctId":"NCT07291869","phase":"NA","title":"Central Venous Catheter Placement With Thoracic Ultrasound and Intracavity ECG Positioning","status":"NOT_YET_RECRUITING","sponsor":"York Teaching Hospitals NHS Foundation Trust","startDate":"2026-01","conditions":"Central Venous Catheter, Point of Care Ultrasound (POCUS), Intracavitary Electrocardiogram Guiding","enrollment":75},{"nctId":"NCT00389142","phase":"","title":"Identifying Genetic Causes of IC/BPS","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2006-01-15","conditions":"Interstitial Cystitis, Bladder Pain Syndrome","enrollment":1000},{"nctId":"NCT07256340","phase":"NA","title":"Measuring Total Energy Expenditure in Critically Ill Patients Using the Doubly Labelled Water Method","status":"RECRUITING","sponsor":"Maastricht University Medical Center","startDate":"2025-12-01","conditions":"Critical Illness","enrollment":50},{"nctId":"NCT03828773","phase":"NA","title":"PTX3-targeted Antifungal Prophylaxis","status":"RECRUITING","sponsor":"Bochud Pierre-Yves","startDate":"2019-02-11","conditions":"Candidiasis, Fungal Infection, Acute Myeloid Leukemia","enrollment":410},{"nctId":"NCT06733038","phase":"PHASE3","title":"FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.","status":"RECRUITING","sponsor":"Gruppo Oncologico del Nord-Ovest","startDate":"2024-11-15","conditions":"Colorectal Cancer","enrollment":238},{"nctId":"NCT07183059","phase":"NA","title":"A Single Center Prospective Study in an Estimated 570 Patients Who Underwent Genetic Screening at UZ Brussel in the Context of a Primary Cardiac Arrhythmia. Patients Showing a Variant Class 3,4 or 5 in SCN4A or CLCN1 Will Undergo a Clinical and Electrophysiological Review After IC.","status":"NOT_YET_RECRUITING","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2025-12-15","conditions":"Non Dystrophic Myotonia, Arrythmia, Cardiac","enrollment":570},{"nctId":"NCT05149573","phase":"NA","title":"Investigation of PEMF Therapy for Female Patients With IC/BPS","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2022-08-29","conditions":"Interstitial Cystitis, Chronic Interstitial Cystitis, Bladder Pain Syndrome","enrollment":75},{"nctId":"NCT01737619","phase":"NA","title":"PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-04-03","conditions":"Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma, Endometrial Serous Adenocarcinoma","enrollment":101},{"nctId":"NCT04124302","phase":"PHASE4","title":"The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.","status":"COMPLETED","sponsor":"Medical University of Warsaw","startDate":"2019-10-01","conditions":"Diabetes Mellitus, Type 1","enrollment":76},{"nctId":"NCT07003113","phase":"NA","title":"Ischemic Preconditioning in Osteoarthritis and Back Pain","status":"RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2025-09-12","conditions":"Low Back Pain, Knee Osteoarthritis","enrollment":24},{"nctId":"NCT03856086","phase":"NA","title":"Comparing Distress Screening + Consultation With Enhanced Usual Care for Caregivers of Cancer Patients","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2019-02-25","conditions":"Cancer Caregivers","enrollment":150},{"nctId":"NCT07227584","phase":"PHASE2","title":"ALL Backbone in AYAs","status":"NOT_YET_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2026-04","conditions":"Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Negative Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL)","enrollment":67},{"nctId":"NCT04729062","phase":"","title":"C3G/Primary IC-MPGN EAP","status":"APPROVED_FOR_MARKETING","sponsor":"Apellis Pharmaceuticals, Inc.","startDate":"","conditions":"C3G, IC-MPGN, C3 Glomerulopathy","enrollment":""},{"nctId":"NCT04084067","phase":"PHASE1","title":"Indocyanine Green (ICG) Guided Tumor Resection","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2020-02-07","conditions":"Neoplastic Disease, Solid Tumor","enrollment":230},{"nctId":"NCT06549790","phase":"PHASE1","title":"Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"Nerviano Medical Sciences","startDate":"2024-10-16","conditions":"Relapsed/Refractory Acute Myeloid Leukemia","enrollment":124},{"nctId":"NCT06513156","phase":"NA","title":"Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use","status":"RECRUITING","sponsor":"Elana Rosenthal","startDate":"2024-10-01","conditions":"Opioid Use Disorder, Injection Related Infections, Stimulant Use Disorder","enrollment":304},{"nctId":"NCT05050643","phase":"NA","title":"High-Risk Veteran Initiative","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2021-07-23","conditions":"Multimorbidity","enrollment":17},{"nctId":"NCT03059940","phase":"EARLY_PHASE1","title":"Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-06-16","conditions":"Smoking Cessation","enrollment":630},{"nctId":"NCT07208396","phase":"NA","title":"Upper Cervical Mobilization Versus Integrated Neuromuscular Inhibition Technique in Patients With Levator Scapulae Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-10-20","conditions":"Levator Scapulae Syndrome","enrollment":60},{"nctId":"NCT03204825","phase":"NA","title":"Pain Management and Patient Education for Physical Activity in Intermittent Claudication (PrEPAID)","status":"COMPLETED","sponsor":"Glasgow Caledonian University","startDate":"2017-08-01","conditions":"Peripheral Arterial Disease, Intermittent Claudication","enrollment":95},{"nctId":"NCT05556720","phase":"PHASE3","title":"Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Monash University","startDate":"2022-12-01","conditions":"HIV, Organ Transplantation, Lymphoma, Non-Hodgkin","enrollment":960},{"nctId":"NCT04748861","phase":"NA","title":"CYCLE-AD (CYcling to Cease or Limit the Effects of Alzheimer's Disease)","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2021-10-20","conditions":"High Intensity Exercise, Normal Cognition, Exercise Intervention","enrollment":150},{"nctId":"NCT06199050","phase":"NA","title":"The Effect of 360° Virtual Reality Movies on Fear and Anxiety","status":"COMPLETED","sponsor":"Maastricht Radiation Oncology","startDate":"2023-06-16","conditions":"Fear, Anxiety, Breast Cancer","enrollment":292},{"nctId":"NCT03396081","phase":"NA","title":"Efficacy of PRADO Heart Failure in Occitania","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2018-05-04","conditions":"Heart Failure","enrollment":404},{"nctId":"NCT06027294","phase":"NA","title":"Blood Flow Regulation and Neuromuscular Function Post-Stroke","status":"RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2024-01-11","conditions":"Stroke","enrollment":40},{"nctId":"NCT05870748","phase":"PHASE2, PHASE3","title":"REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1","status":"TERMINATED","sponsor":"Sutro Biopharma, Inc.","startDate":"2023-07-12","conditions":"Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer","enrollment":600},{"nctId":"NCT06488092","phase":"NA","title":"IC-CS Risk: Patient Outcomes","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2024-09-01","conditions":"Cesarean Delivery","enrollment":20000},{"nctId":"NCT05919394","phase":"PHASE4","title":"Triple vs High Dose Inhaled CORticosteroids","status":"WITHDRAWN","sponsor":"Galaxia Empírica","startDate":"2023-06-01","conditions":"Asthma","enrollment":""},{"nctId":"NCT04384627","phase":"PHASE3","title":"Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2019-12-01","conditions":"Nasopharyngeal Carcinoma, Induction Chemotherapy, Radiotherapy","enrollment":445},{"nctId":"NCT06114732","phase":"NA","title":"Motivating Physical Activity With Behavioural interVention and Electrical Stimulation Remotely in Intermittent Claudication","status":"RECRUITING","sponsor":"Glasgow Caledonian University","startDate":"2024-01-29","conditions":"Peripheral Artery Disease, Intermittent Claudication","enrollment":48},{"nctId":"NCT05230511","phase":"PHASE2","title":"Intravesical LGG VS Saline Bladder Wash RCT","status":"RECRUITING","sponsor":"Medstar Health Research Institute","startDate":"2022-06-13","conditions":"Spinal Cord Injuries, Neurogenic Bladder","enrollment":120},{"nctId":"NCT04209855","phase":"PHASE3","title":"A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression","status":"COMPLETED","sponsor":"AbbVie","startDate":"2019-12-31","conditions":"Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer","enrollment":453},{"nctId":"NCT04734106","phase":"EARLY_PHASE1","title":"Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2025-02-18","conditions":"Interstitial Cystitis, Chronic Interstitial Cystitis, Bladder Pain Syndrome","enrollment":30},{"nctId":"NCT05059444","phase":"","title":"ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation","status":"RECRUITING","sponsor":"Guardant Health, Inc.","startDate":"2021-09-07","conditions":"Bladder Carcinoma, Ureter Carcinoma, Renal Pelvis Carcinoma","enrollment":2020},{"nctId":"NCT06096597","phase":"PHASE2, PHASE3","title":"Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome","status":"RECRUITING","sponsor":"David Sheyn","startDate":"2024-07-24","conditions":"Interstitial Cystitis, Painful Bladder Syndrome, Painful Bladder Syndrome (PBS)","enrollment":100},{"nctId":"NCT07121920","phase":"NA","title":"Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBD","status":"NOT_YET_RECRUITING","sponsor":"Cook Children's Health Care System","startDate":"2025-09-01","conditions":"IBD (Inflammatory Bowel Disease), IBD, IBD - Inflammatory Bowel Disease","enrollment":40},{"nctId":"NCT04341636","phase":"NA","title":"A Comparison of the Accurate Diagnosis of the Horizontal & Vertical Bitewing Images","status":"COMPLETED","sponsor":"King Abdulaziz University","startDate":"2023-05-15","conditions":"Periodontal Diseases, Dental Caries","enrollment":20},{"nctId":"NCT05921903","phase":"PHASE2","title":"A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2023-07-28","conditions":"Respiratory Syncytial Virus Infections","enrollment":386},{"nctId":"NCT07108517","phase":"NA","title":"A Manualized Post-Traumatic Growth Intervention for People With Cancer in Greece - IC-Growth","status":"RECRUITING","sponsor":"Centre for Research and Technology Hellas","startDate":"2025-05-01","conditions":"Breast Cancer, Colon Cancer, Head and Neck Cancers","enrollment":180},{"nctId":"NCT07108855","phase":"PHASE1, PHASE2","title":"Detection of Upper Gastrointestinal Tumour Depth and Demarcation Using Systemic Administration of Indocyanine Green During Endoscopic Submucosal Dissection","status":"RECRUITING","sponsor":"University Medical Center Groningen","startDate":"2025-09-01","conditions":"Esophageal Carcinoma, Gastric Carcinoma","enrollment":10}],"_emaApprovals":[],"_faersSignals":[{"count":36,"reaction":"PRODUCT SUBSTITUTION ISSUE"},{"count":32,"reaction":"HEADACHE"},{"count":29,"reaction":"DRUG INEFFECTIVE"},{"count":21,"reaction":"NAUSEA"},{"count":20,"reaction":"INSOMNIA"},{"count":18,"reaction":"ANXIETY"},{"count":17,"reaction":"PAIN"},{"count":16,"reaction":"ARTHRALGIA"},{"count":16,"reaction":"DIARRHOEA"},{"count":15,"reaction":"ABDOMINAL PAIN UPPER"}],"_approvalHistory":[],"publicationCount":123482,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Platinol-AQ (cisplatin), CPT-11 (irinotecan)"],"phase":"marketed","status":"active","brandName":"IC","genericName":"IC","companyName":"Alliance for Clinical Trials in Oncology","companyId":"alliance-for-clinical-trials-in-oncology","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}